Correspondence charlotte.scott@irc.vib-ugent.be (C.L.S.), martin.guilliams@irc.vib-ugent.be (M.G.) In Brief Scott et al. demonstrate that ZEB2 is critical for maintaining the tissue identities of macrophages. Loss of ZEB2 results in tissue-specific changes in different macrophage populations and their subsequent disappearance. In Kupffer cells, ZEB2 maintains LXRa expression, loss of which reproduces the change in Kupffer cell identity and their disappearance.
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Loss of Zeb2 alters the transcriptome of macrophages in a tissue-specific manner
INTRODUCTION
Most macrophages (macs) arise during embryogenesis from either yolk-sac macs or fetal liver monocytes and self-maintain throughout life in most tissues (Ginhoux and Guilliams, 2016) . In a selection of tissues including the heart, gut, and dermis, this self-maintenance is partially abrogated resulting in the continual replenishment of these macs from bone marrow (BM) monocytes (Ginhoux and Guilliams, 2016) . In addition, macs across different organs are highly heterogeneous (Gautier et al., 2012; Gosselin et al., 2014; Lavin et al., 2014) and contribute to tissue homeostasis by performing different ''accessory functions'' in their specific tissues of residence (Okabe and Medzhitov, 2016) . Research has recently been focused on understanding the heterogeneity of macs from one tissue to another, but it remains largely unknown if macs also require some conserved factors for their identity, irrespective of their tissue of residence. While high expression of the transcription factor (TF) PU.1 (Monticelli and Natoli, 2017) and dependence on signaling through the colony stimulating factor-1 receptor (CSF1R) (Gow et al., 2014; Hume et al., 1988; Tagliani et al., 2011; Wang et al., 2012) are characteristics of the mac lineage, not much else is known regarding additional conserved TFs that drive and maintain these cells.
Zinc finger E box binding homeobox 2 (ZEB2, SIP1, ZFXH1B) is a TF best known for its role in epithelial to mesenchymal transition (EMT), in which epithelial cells lose their cellular identity and are converted into mesenchymal cells (Brabletz and Brabletz, 2010) . EMT transitions are crucial in embryonic development, wound healing, and cancer (De Craene and Berx, 2013) . Mice lacking Zeb2 are embryonic lethal (Higashi et al., 2002) , while patients with heterozygous abnormalities in Zeb2 often develop Hirschsprung's disease and Mowat-Wilson syndrome (Vandewalle et al., 2009 ). In the immune system, it has recently been reported that ZEB2 functions to regulate NK cell maturation (van Helden et al., 2015) , the terminal differentiation of CD8 + effector T cells (Dominguez et al., 2015; Omilusik et al., 2015) , and the differentiation and development of pDCs and cDC2s (Scott et al., 2016a; Wu et al., 2016) . Additionally, ZEB2 has been suggested to play a role in controlling the fate of the granulocyte-macrophage progenitor (GMP) (Wu et al., 2016) . Here, we examined Zeb2 expression in a variety of mac populations and show that high expression of Zeb2 is a conserved feature of the mac lineage. Furthermore, we found that loss of ZEB2 in five different macs resulted in the loss of their tissue identities and their subsequent disappearance. More specifically, we found that ZEB2 functions to maintain KC identity, at least in part, by regulating expression of the TF LXRa (Nr1h3).
RESULTS

Zeb2 Expression Is Conserved across the Mac Lineage
Although macs represent a highly heterogeneous lineage (Gautier et al., 2012; Lavin et al., 2014; Scott et al., 2016b) , we sought here to identify TFs conserved across the mac lineage. To this end, we compiled data from the Immgen Consortium, our previously published studies (Scott et al., 2016b; van de Laar et al., 2016) and data generated during this study. This comparison yielded a list of 67 core mac genes ( Figure S1A ). Included in this list are genes previously ascribed to the mac lineage including Fcgr1, Mertk, and Cd14 (Gautier et al., 2012; , as well as the TF Zeb2. While this TF has also recently been identified as a core gene in pre-macs (Mass et al., 2016) , its precise role within the mac lineage has not been investigated.
Loss of ZEB2 in KCs and AMs Results in an Altered
Phenotype Given that Zeb2 À/À mice are embryonic lethal (Higashi et al., 2002) , we utilized CRE-LOX systems to specifically remove Zeb2 from different mac subsets. Based on Zeb2 expression ( Figure S1A ), we first examined the effects of Zeb2 loss in KCs (higher Zeb2) and AMs (lower Zeb2). Having recently shown that the C-type lectin, Clec4F, is exclusively expressed by murine KCs (Scott et al., 2016b) Figure 1A ). This suggests that ZEB2 might be important for KCs and also highlights the importance of examining tissue-specific mac markers. As ZEB2 appears to play a role in KCs, we next examined if it also was required by AMs. To remove ZEB2 from AMs, we made use of Itgax-cre mice, which efficiently target AMs alongside a number of other CD11c-expressing cells (Durai and Murphy, 2016) . By crossing the Itgax-cre mice to Rosa26-RFP reporters we confirmed that AMs were efficiently targeted ( Figure S1F ). Analysis of the total AM population in fl/fl and Zeb2 fl/fl controls revealed a slight reduction in AMs ( Figure 1B ).
In addition, the loss of Zeb2 from CD11c-expressing cells also altered the surface phenotype of the remaining AMs with a proportion expressing CD11b in the CRE + mice ( Figure 1B ). , poor quality, contaminating, and actively proliferating cells were excluded ( Figure S1G ) and t-SNE plots with both CRE À and CRE + cells combined for KCs or AMs were generated ( Figures 1C and 1D) Figure S1 .
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to as group 0) and 3 distinct groups of CRE + cells (cluster 6 = group 1, cluster 5 = group 2 and clusters 1+3 = group 3) ( Figure 1C ). For the AMs, we identified 1 group of CRE À cells (group 0; clusters 0, 2, 5, 8), one group of mixed CRE À and CRE + cells (group 1 = cluster 6), and three groups of CRE + cells (group 2 = cluster 3, group 3 = clusters 1 + 4 and group 4 = cluster 7) ( Figure 1D ). Next, we examined Zeb2 expression between the groups. However, as the Zeb2 fl/fl construction generates a truncated form of the mRNA possessing a 3' end it was not possible to determine which cells express full-length or floxed mRNA with the 3' Assay from 10X Genomics. Figure 1G & Table S1 ) and identified SiglecF and CD20 (Ms4a1) to be markers that could potentially be used to distinguish between the groups of CRE + cells (Figure 1E) . For the AMs, this analysis identified 821 DE genes for group 0, 312 for group 1, 230 for group 2, 929 for group 3 and 883 in group 4 ( Figure 1H & Table S2 ) and identified CD326 (Epcam) and CD101, as two markers which could distinguish between the groups of CRE + cells ( Figure 1F ). We next examined expression of these markers by flow cytometry. While not expressed by KCs from Zeb2 fl/fl mice, SiglecF and CD20 were found to be expressed by a proportion of KCs in Clec4f-crexZeb2 fl/fl mice at 6 weeks of age ( Figure 2A À/À cells due to their increased expression of MHCII pathway associated genes ( Figure 1H ). Thus these might represent cells that arise from monocytes, as increased MHCII expression has been reported on monocyte-derived AMs (van de Laar et al., 2016) . Figure 2A ) and Zeb2 À/À AMs ( Figure 2C ) are reduced at 12 weeks of age. This reduction in SiglecF + KCs between 6 and 12 weeks was confirmed by confocal microscopy ( Figure S2C mice, a procedure that has been described to induce KC proliferation (Gow et al., 2014) . Zeb2 -/-KCs proliferated efficiently in response to CSF-1 ( Figure S2H ) indicating that loss of Zeb2 does not block the proliferative capacity of macs, but rather may be required for their maintenance.
Loss of Zeb2 Leads to Mac Disappearance
To examine the idea that loss of Zeb2 induces mac disappearance, we generated BM chimeras in which CD45.1 + mice
were irradiated and reconstituted with congenic CD45.2 + Rosa26-cre ert2 xZeb2 fl/fl BM. Chimeras were made to prevent death of the animals due to Zeb2 loss in non-hematopoietic cells. 6 weeks later, mice were administered tamoxifen for 5 days by oral gavage to induce CRE-mediated loss of Zeb2. KCs and AMs were then examined 2, 6, 20, 34, and 48 days after the last dose of tamoxifen and expression of CD101 and EpCam (Lung AMs) or SiglecF and CD20 (Liver KCs) in donor-derived CD45.2 cells was assessed ( Figure 2G ). Controls include both CD45.2 cells from control mice that were not treated with tamoxifen and host CD45.1 + WT cells from mice treated with tamoxifen ( Figures 2H and 2I ). In the liver, 12.27% ± 3.88% of donorderived KCs expressed SiglecF and CD20 2 days post the last dose of tamoxifen and this rose modestly at day 6. 20 days post the last dose of tamoxifen, SiglecF + CD20 + KCs could no longer be detected in the liver implying that the Zeb2 À/À KCs had disappeared ( Figure 2H ). This disappearance of Zeb2
KCs was confirmed by the PrimeFlow assay, as by day 20 all Zeb2 À/À KCs were lost ( Figure S2I ). In the lung, 2 days post administration of tamoxifen 26.1% ± 4.23% of CD45.2 donor AMs expressed CD101 and EpCam. This further increased to a maximum of 56.4% ± 2.02% six days post the last dose of tamoxifen. At all subsequent time points examined this dropped continuously reaching 10.78% ± 3.25% at day 48 ( Figure 2I ). This disappearance of Zeb2 À/À AMs was also confirmed using the PrimeFlow assay ( Figure S2J ). Taken together, these results demonstrate that ZEB2 is strictly required for the continued presence of macs in tissues and suggest that loss of ZEB2 may result in impaired mac maintenance.
Loss of Zeb2 from KCs but Not AMs, Results in Their
Replenishment from BM We next investigated whether the Zeb2 À/À macs were being replenished from the BM or if mac numbers were maintained solely by local proliferation of Zeb2 +/À counterparts. To examine this, we generated partially-protected chimeras, in which Clec4f-crexZeb2 fl/fl , Itgax-crexZeb2 fl/fl mice or Zeb2 fl/fl littermate controls were irradiated with their livers or lungs protected and reconstituted with congenic CD45.1 WT BM ( Figure 3A) . 4 weeks later, we examined the proportion of CD45.1 + cells within the blood monocytes and KCs in the liver (defined as Clec4F + ) or AMs in the lung (defined as CD11c + SiglecF + ). As the mice were partially protected from irradiation, the animals were between 30%-50% chimeric (calculated by examining chimerism in blood Ly6C hi monocytes). Comparison of the chimerism between the blood monocytes and liver KCs found that KCs were chimeric ( Figure 3B) ; however, lung AMs displayed very low chimerism ( Figure 3C ). To further investigate how Zeb2 À/À macs were being lost and replaced by Zeb2 +/À counterparts, we next questioned whether the macs were dying in the absence of ZEB2. We examined expression of a number of genes associated with distinct cell death pathways in our SC-RNA-Seq analysis. Although a number of these genes were either not expressed or their expression was not altered in Zeb2 Figure 3G ). As the gene-expression profiles of different tissue macs have been shown to be highly heterogeneous and ZEB2 is known for its role in altering cellular identities in EMT, we next hypothesized that ZEB2 might control the tissue-specific identities of the different mac populations, with its loss rendering the macs less suited to their niche resulting in their subsequent loss. To examine this, we investigated how the core KC and AM transcriptional profile changed in the absence of ZEB2. As additional mac populations have been sequenced since the core profiles of these two macs were described (Gautier et al., 2012; Scott et al., 2016b) , we first redefined these profiles. Thus, we compared the transcriptional profile of AMs, KCs, microglia, peritoneal macs, colonic macs (CMs), and splenic red pulp macs (SMs) (Lavin et al., 2014) and identified the genes specific to the KCs and AMs ( Figure S3 ). As there was considerable overlap between the transcriptional profiles of KCs and SMs, SMs were excluded when defining the core profile of KCs and vice versa. Furthermore, as these core lists were defined on the basis of bulk RNA seq data, we performed an additional control whereby to be a core gene, it must be expressed in at least 20% of our Zeb2 fl/fl KCs and AMs profiled by SC-RNA-seq (Figure S3 ). This was required because previously reported core mac gene lists contained genes expressed by contaminating cells (Lynch et al., 2018) . We next compared how expression of the top core genes were altered upon loss of ZEB2 and found that there were numerous changes to the core profiles of both mac populations with 60% of the KC tissue-specific genes and 72% of the AM tissue-specific genes affected by the loss of Zeb2 ( Figures 3H and 3I ), suggesting ZEB2 might play a role in maintaining the tissue-specific identities of these macs.
Loss of KC Identity in Absence of ZEB2 Is in Part Due to the Loss of LXRa We next examined the mechanism through which ZEB2 could control mac tissue-specific identities. For this, we focused on the KCs. The tissue-specific identity of macs has been proposed to be controlled by a small set of tissue-specific TFs (Lavin et al., 2014) . Nr1h3 (encoding LXRa) was reported to be highly expressed by KCs (Mass et al., 2016) and was among the list of DE core KC identity genes in KCs lacking Zeb2 ( Figure 3H ). Thus, we hypothesized, that ZEB2 might control KC identity by regulating LXRa expression. LXRa was previously reported to be dispensable for KC development and survival, but this was based solely on F4/80 and CD68 expression (A-Gonzalez Figure 4A ). However, as for the loss of Zeb2, it altered the proportions of cells expressing Clec4F and Tim4 ( Figure 4B ). Protected chimeras demonstrated that in the absence of Nr1h3, KCs were being replaced from a BM source ( Figure 4C ). As these data suggest that ZEB2 might function to control KC identity through maintaining LXRa expression, we next determined whether the effect of Zeb2 loss on the KCs transcriptome might reflect loss of LXRa-dependent genes. Figure 4E and Table   S3 ) and many of these DE genes were also core KC genes including Cdh5, Pcolce2, Kcna2, C6, and Il18bp ( Figure 3H ) and were similarly lost upon loss of Zeb2 ( Figure 4E ). Moreover, we were able to confirm this downregulation in both Zeb2 À/À and Nr1h3 À/À KCs by flow cytometry ( Figures 4F and 4G ) or qRT-PCR ( Figures S4B and S4C ). As loss of ZEB2 and LXRa led to replacement of the KCs from the BM, we noticed that a number of the DE genes were also related to origin of the KCs. To remove any DE genes associated with mac origin and hence only examine DE genes resulting from the loss of LXRa or ZEB2, we used our previously published data (Scott et al., 2016b) and identified any DE genes between moKCs from KC-DTR mice 15 days post treatment with DT and embryonic KCs ( Figure S4D Figure S5 ). Fcgr1-crexRosa26-RFP mice revealed that SMs, microglia, and CMs were efficiently targeted with this CRE (Figures S5A-S5D ). However, a number of other immune cells are also targeted in these mice. This includes CD64 À B cells, T cells, cDC1s, and cDC2s ( Figure S5A ). Fcgr1-crexZeb2 fl/fl mice had no change in the proportion or number of the total SM population defined as Lin À CD64 + F4/80 + ( Figure 5A ), but a proportion of these macs gained expression of CD11b in the absence of Zeb2 ( Figure 5A ). In addition, we observed a reduction in absolute number of microglia ( Figure 5B ) and Zeb2 À/À microglia were found to upregulate their expression of CD11c ( Figure 5B ). To examine whether ZEB2 also functions in the maintenance of BM monocyte-derived macs, we next examined whether Zeb2 was also required in CMs which are constantly replaced by BM monocytes during adulthood along a trajectory dubbed the ''monocyte-waterfall'' Tamoutounour et al., 2012) . Analysis of the monocyte-waterfall in Fcgr1-crexZeb2 fl/fl mice identified a reduction in the proportion and number of mature CMs alongside an increase in the proportion and number of Ly6C + MHCII + transitioning monocytes ( Figure 5C ). To determine whether these changes reflected altered tissuespecific identities of these macs, we next performed SC-RNAseq analysis. Following the same pre-processing as above (Figure S1G) , we used expression of Zeb2, Ms4a1, Siglecf, Cd101, or Epcam to identify Zeb2 À/À macs in the spleen, brain, and colon ( Figure 6 ). Note that, as was observed for the lung and liver, the Zeb2 À/À macs in the spleen, brain, and colon expressed higher Zeb2, again suggesting a feedback mechanism in the Zeb2 À/À macs ( Figure 6 ). Figure 6A ). In addition, we identified 2 groups of cells in the microglia (group 0; Zeb2 +/+ macs from the CRE À mice and group 1; Zeb2 À/À macs from Figure S4 .
the CRE + mice expressing higher Zeb2, Siglecf, and Cd101) (Figure 6B) . While we performed the SC-RNA-seq analysis on total CMs ( Figure 6C ), we found these could be divided into two main groups of cells, those expressing high Cd74 (coding for the MHCII-associated invariant chain), H2-Aa, H2-Eb1, and Itgax (coding for CD11c) and those expressing low Cd74 ( Figure 6C Figure 6D) .
To examine the effects of loss of ZEB2 on mac identity, we next determined the core profiles of these macs as described above ( Figures S7A-S7C ) and examined the expression of these identity genes in the Zeb2 À/À macs. As for the liver and lung, this revealed that the core profiles of the different macs were altered in the absence of Zeb2 (60% in SMs and microglia and 76% in CMs; Figures 7A-7C , with indicated groups from Figure 6 ). Consistent with the data from the liver and lung ( Figures  2G-2I) , Zeb2 À/À SMs were also found to disappear in mice in which Zeb2 loss was induced by tamoxifen administration (Figures S7D and S7E) . The brain and colon were unfortunately not assessed but the conserved effects in the liver, lung, and spleen coupled with the reduced population of microglia and increased turnover of CMs strongly suggests that loss of Zeb2 induces mac disappearance across tissues. To further confirm that the loss of ZEB2 results in tissue-specific changes, we examined the overlap between the DE genes in the 5 tissues (Tables S1, S2 , S4, S5 and S6) and generated a single t-SNE file containing all Zeb2 +/+ and Zeb2 À/À macs from the 5 organs ( Figure 7D ). This demonstrated that loss of Zeb2 did not direct the cells from each tissue along a single component in the tSNE plot, suggesting the changes were predominantly tissuespecific. Additionally, we found that the majority of DE genes were specifically altered in only one of the 5 tissues ( Figure 7E ) with only 32 DE genes being shared by all tissues (Figures 7E  and 7F ). Taken together, these data highlight that loss of Zeb2 has a striking tissue-specific effect on mac identity.
DISCUSSION
TFs are at the core of lineage specification and commitment through regulation of gene expression. TFs can function at various stages in a cell, during development and/or in the maintenance of the terminally-differentiated cells, as well as in controlling specific cellular functions. While a number of TFs have recently been identified in specific mac populations including ID3 in KCs (Mass et al., 2016) , PPARg in AMs (Schneider et al., 2014) and GATA6 in peritoneal macs (Lavin et al., 2014; Okabe and Medzhitov, 2014) , the TFs governing the entire mac lineage aside from PU.1 remain to be fully investigated. Here we report that Zeb2 is highly expressed in macs across tissues. In addition, Zeb2 has been reported to already be expressed in the embryonic pre-macs (Mass et al., 2016) . Our data indicate that ZEB2 was required to maintain the cellular identity of macs with its loss leading to their disappearance from all tissues studied. Therefore, just as ZEB2 controls cell identity in EMT (Brabletz and Brabletz, 2010) it is essential for the maintenance of mac identities across tissues. SC-RNA-seq analysis of the different mac populations revealed that Zeb2 was often not efficiently deleted in all macs using the three distinct CRE models we employed, with Zeb2 +/À populations being observed in all organs except the brain. The mechanism by which some Zeb2 +/À macs retain one unfloxed
Zeb2 allele remains unclear and requires further investigation. Zeb2 À/À macs were distinguished from Zeb2 +/À counterparts within the same mouse on the basis of their phenotype. KCs expressed SiglecF and CD20 (encoded by Ms4a1) following loss of Zeb2, while AMs expressed CD101 and EpCam. These markers, although not conserved between all the mac populations, were conserved in a number of the populations and with Zeb2-deficient cDC2s (Scott et al., 2016a) suggesting that ZEB2 expres- In terms of understanding mac ontogeny, we recently proposed the mac niche hypothesis (Guilliams and Scott, 2017) . We suggested that niche availability and niche accessibility would be the two main factors determining mac ontogeny. Loss of ZEB2 within mature macs induces mac disappearance, which creates niche availability. We found that these lost macs are replaced (in part) by cells of BM origin (likely BM monocytes) in the liver but not to any great extent in the lung. It is worth noting, however, that we do see a small population of MHCII-expressing AMs in the SC-RNA-seq analysis and found few BM-derived cells in the chimeras, indicating that a minor fraction of AMs could be replaced by monocytes. This major replacement of KCs but minor replacement of AMs is in line with our niche hypothesis (Guilliams and Scott, 2017) as only the liver mac niches are accessible to progenitors circulating in the blood as liver KCs reside in the bloodstream of the liver sinusoids while the AM niches are protected by the lung epithelial barrier. However, we only see a small reduction in total AM cell number following loss of ZEB2 despite there being very limited replenishment from the BM. This is because the Zeb2 +/À AMs present were sufficient to refill the niche with time through local proliferation. Proliferation of Zeb2 +/À macs also contributed to mac maintenance in the liver.
The dual mechanism of replacement in the liver via both BM precursors and local proliferation is consistent with our previous study whereby partial depletion of KCs using the Clec4f-Dtr mice led to reconstitution of the mac pool via the same two mechanisms (Scott et al., 2016b) . This highlights the crucial requirement for ZEB2 within the mac lineage as Zeb2 À/À macs are outcompeted from the mac niche, regardless of the repopulation mechanism. How does ZEB2 function to maintain the mac lineage? We propose that loss of ZEB2 leads to loss of the mac tissue-specific identities. In KCs, loss of Zeb2 leads to loss of Nr1h3, suggesting that one mechanism of action of ZEB2 is to maintain the expression of TFs driving the tissue-specific identities of the different mac populations. We found that loss of LXRa in KCs recapitulated the main traits of Zeb2 À/À KCs including loss of KC identity and disappearance from the liver, suggesting that downregulation of LXRa is at least in part responsible for the phenotype of Zeb2 À/À KCs. The mechanisms underlying the control of tissue-specific identities by Zeb2 in other organs remain to be investigated. However, the reduced expression of the TF Cebpb in the Zeb2 À/À AMs, a TF recently reported to be essential for AMs (Cain et al., 2013) , suggests that loss of Zeb2 might control mac identity globally by regulating expression of tissue-specific TFs in the different macs, and we are currently investigating this.
In conclusion, our study highlights that Zeb2 expression is a defining characteristic of the mac lineage. ZEB2 is crucial for the maintenance of macs, with its absence leading to changes in their transcriptional profiles, including loss of roughly 60% of their tissue-specific identities potentially through the decreased expression of tissue-specific TFs, such as LXRa in KCs. This loss of identity inevitably results in mac disappearance, possibly due to death by necroptosis, identifying ZEB2 as a crucial TF in mac biology and LXRa as a master TF in KCs.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS In Vivo Animal Studies
The following mice were used in this study; Zeb2 fl/fl (Higashi et al., 2002) , Nr1h3 fl/fl Itgax-cre (Caton et al., 2007) , Rosa-RFP (Luche et al., 2007) , Rosa-26-cre ert2 (Ventura et al., 2007) , Clec4f-cre (B6-Clec4f tm3Ciphe ; were developed by the Centre d'Immunophenomique, Marseille, France) and ; generated by Bernard Malissen). All mice were used on a C57Bl/6 background and a mix of male and female mice were used for each experiment. Mice were used between 6 and 8 weeks of age unless otherwise stated. All mice were bred and maintained at the VIB (Ghent University) under specific pathogen free conditions. All animals were randomly allocated to experimental groups and littermate controls were used in all experiments. All experiments were performed in accordance with the ethical committee of the Faculty of Science of the VIB.
Bulk RNA Sequencing 25,000 KCs or AMs were FACS-purified into 500ml of RLT plus buffer (QIAGEN) and b-mercaptoethanol. RNA was isolated using a RNeasy Plus micro kit (QIAGEN) and sent to the VIB Nucleomics facility, where the RNA sequencing was performed using a NextSeq sequencer (Illumina). The pre-processing of the RNA sequencing data was done by Trimmomatic. The adapters were cut and reads were trimmed when the quality dropped below 20. Reads with a length <35 were discarded. All samples passed quality control based on the results of FastQC. Reads were mapped to the mouse reference genome via Tophat2 and counted via HTSeqCount. Samples were subsequently analyzed using R/Bioconductor, and the limma (voom) procedure was used to normalize the data. cryostat tissue sections were labeled overnight at 4 C with primary antibodies followed by incubation for 1 hour at room temperature with secondary antibodies. When two rat antibodies were used on the same section, the directly conjugated rat antibody was incubated for 1h after blocking with a donkey anti-rat secondary antibody with 1% rat serum for 30 minutes. Slices were mounted on ProLong Diamond (Thermo Fisher Scientific) and imaged with a Zeiss LSM 780 confocal microscope (Carl Zeiss, Oberkochen, Germany). Images were analyzed using ImageJ software.
PCR Analysis of Zeb2 Deletion 25000 cells of required phenotype and genotype were FACS-purified from livers and lungs of Clec4f-crexZeb2 fl/fl and Itgax-crexZeb2 fl/fl mice respectively. DNA was extracted by boiling the cells at 95C in 50ml 50mM NaOH for 20minutes. After boiling 5ml 1.5M Tris pH8.8 was added to the cells. 1 or 0.2ml pf extracted DNA was added to a PCR reaction containing primer pairs (Zeb2 PCR) listed in the key resource table and Allin Red Taq polymerase (HighQu). PCR protocol was as follows: 95C 1min, 40 cycles of 95C 15secs, 62C 15secs, 72C 30secs and a 5min incubation at 72C. PCR products were resolved on a 2% agarose gel.
QUANTIFICATION AND STATISTICAL ANALYSIS
In all experiments, data are presented as mean ± SEM unless stated otherwise. Statistical tests were selected based on appropriate assumptions with respect to data distribution and variance characteristics. Student's t test (two-tailed) was used for the statistical analysis of differences between two groups. One-way ANOVA with Bonferroni post-test was used for the statistical analysis of differences between more than two groups. Statistical significance was defined as p < 0.05. Sample sizes were chosen according to standard guidelines. Number of animals is indicated as ''n.'' Of note, sizes of the tested animal groups were also dictated by availability of the transgenic strains and litter sizes, allowing littermate controls. Pre-established exclusion criteria are based on IACUC guidelines. The investigator was not blinded to the mouse group allocation.
DATA AND SOFTWARE AVAILABILITY
All RNA-sequencing data have been deposited in the Gene Expression Omnibus public database under accession number GSE117081.
